GlassScriptPhysician profile
Eric H Liu
NPI 1174763031
$528,834.90
in general payments reported to CMS, 2019-2025
54 companies · $134K in 2025
The $134K reported for 2025 was more than what 99% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93K · 2020: $78K · 2021: $65K · 2022: $69K · 2023: $52K · 2024: $38K · 2025: $134K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $146K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $40K · Travel and Lodging: $19K · Food and Beverage: $12K · Debt Forgiveness: $3,980 · Honoraria: $3,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $146,400.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $39,600.00 |
| Travel and Lodging | $19,034.15 |
| Food and Beverage | $11,831.94 |
| Debt Forgiveness | $3,980.00 |
| Honoraria | $3,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $216,157.22 | 2020-2025 | Xermelo, Zoladex |
| Ipsen Biopharmaceuticals, INC | $78,255.33 | 2019-2023 | Onivyde, Somatuline Depot |
| Abbvie INC. | $64,814.07 | 2019-2025 | |
| Lexicon Pharmaceuticals, INC. | $45,556.42 | 2019-2020 | |
| Advanced Accelerator Applications | $36,019.26 | 2019-2020 | |
| Curium US LLC | $22,079.13 | 2019-2025 | Detectnet |
| Sun Pharmaceutical Industries INC. | $11,778.25 | 2020-2024 | |
| Exelixis INC. | $9,331.34 | 2024-2025 | Cabometyx |
| Novartis Pharmaceuticals Corporation | $8,845.16 | 2019-2025 | |
| Histosonics, INC. | $6,573.63 | 2024-2025 | |
| Acera Surgical, INC. | $5,825.91 | 2023-2025 | Restrata Wound Matrix |
| Sirtex Medical INC | $4,316.56 | 2022-2023 | Sir-Spheres Microspheres |
| Ipsen Bioscience INC. | $4,000.00 | 2021 | |
| Angiodynamics, INC. | $3,274.05 | 2019-2024 | Nanoknife, Angiodynamics, Solero |
| Baxter Healthcare | $2,971.37 | 2019-2024 | Floseal, Tisseel |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $2,209.93 | 2019-2025 | Certus 140, Vistaseal, Surgiflo Hemostatic Matrix |
| Davol INC. | $1,255.66 | 2019-2025 | Phasix Mesh, Arista Ah Flexitip |
| Intuitive Surgical, INC. | $744.16 | 2019-2023 | Da Vinci Surgical System |
| Tosoh Bioscience, INC. | $677.00 | 2019 | |
| Stryker Corporation | $643.62 | 2019-2024 | Spy-Phi System, 1688, Pinpoint |
| Becton, Dickinson and Company | $431.69 | 2023-2025 | Arista Ah Flexitip, Phasix Mesh |
| Aroa Biosurgery Incorporated | $356.63 | 2022-2023 | |
| Recordati_rare_diseases_inc. | $328.25 | 2021-2025 | Isturisa, Signifor Lar |
| Avanos Medical | $274.33 | 2022-2024 | On-Q* Pump and Accessories, Quikbloc |
| Biocryst US Sales Co., LLC | $165.06 | 2023-2025 | Orladeyo |
| Dilon Technologies, INC. | $148.32 | 2024-2025 | Hemoblast Bellows |
| Jazz Pharmaceuticals INC. | $137.94 | 2025 | |
| Acell, INC. | $137.37 | 2020 | |
| Mirati Therapeutics, INC. | $122.96 | 2023 | Krazati |
| Aadi Bioscience, INC. | $113.64 | 2024 | Fyarro |
| Caris Mpi, INC. | $111.34 | 2025 | Mi Cancer Seek |
| Teleflex LLC | $97.20 | 2025 | Quikclot |
| Medtronic, INC. | $96.59 | 2021-2025 | Emprint |
| Merit Medical Systems INC | $96.00 | 2023 | Savi Scout |
| Novo Nordisk INC | $93.37 | 2023 | Wegovy |
| Takeda Pharmaceuticals U.S.A., INC. | $90.21 | 2022-2024 | Gattex |
| Celgene Corporation | $88.71 | 2021 | |
| Baudax Bio INC. | $80.82 | 2020 | |
| Eusa Pharma (US) LLC | $77.64 | 2022 | |
| Terumo Medical Corporation | $56.74 | 2023 | Hydropearl |
| Medtronic USA, INC. | $54.77 | 2019 | |
| Eisai INC. | $48.00 | 2023-2024 | |
| W. L. Gore & Associates, INC. | $45.13 | 2021 | |
| Tela Bio, INC. | $41.08 | 2021 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $39.83 | 2025 | |
| Tempus Ai, INC | $25.21 | 2024 | |
| Axsome Therapeutics, INC. | $22.88 | 2024 | Sunosi |
| Astellas Pharma US INC | $21.94 | 2023 | |
| Smith+Nephew, INC. | $21.85 | 2024 | Versajet |
| Conmed Corporation | $20.10 | 2025 | Airseal |
| Merck Sharp & Dohme LLC | $17.97 | 2025 | Welireg |
| Edwards Lifesciences Corporation | $15.16 | 2024 | Hemosphere |
| Bolder Surgical LLC | $15.10 | 2021 | |
| Rigel Pharmaceuticals, INC. | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.